China Animal Vaccine Industry  Report, 2010-2011 August 2011
<ul><li>This report  </li></ul><ul><li>Analyzes the status quo of China animal vaccine industry & market. </li></ul><ul><l...
<ul><li>Market Scale and YoY Growth Rate of China Animal Vaccine Industry, 2006-2010 (Unit: RMB bn) </li></ul><ul><li>Sour...
<ul><li>In recent year, the scope of China animal compulsory vaccination is  </li></ul><ul><li>being gradually expanded. C...
<ul><li>4.1.4 Porcine Circovirus Vaccine </li></ul><ul><li>4.2 Poultry Vaccines </li></ul><ul><li>4.2.1 Newcastle Disease ...
<ul><li>Animal Vaccine Types and Characteristics </li></ul><ul><li>Animal Vaccine Industry Chain </li></ul><ul><li>Amount ...
<ul><li>China’s Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2010 </li></ul><ul><li>Origins of China’s...
<ul><li>Animal Vaccine Capacity Distribution of Jinyu Group </li></ul><ul><li>Animal Vaccine Revenue and Gross Margin of J...
<ul><li>Gross Margin of Tianjin Ringpu Bio-technology by Product, 2007-2010 </li></ul><ul><li>Sales Revenue from Governmen...
<ul><li>You can place your order in the following alternative ways: </li></ul><ul><li>Order online at  www.researchinchina...
Upcoming SlideShare
Loading in...5
×

China animal vaccine industry report, 2010 2011

1,399

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,399
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "China animal vaccine industry report, 2010 2011"

  1. 1. China Animal Vaccine Industry Report, 2010-2011 August 2011
  2. 2. <ul><li>This report </li></ul><ul><li>Analyzes the status quo of China animal vaccine industry & market. </li></ul><ul><li>Focuses on the human vaccine market segments in China, including Swine Vaccines and Poultry Vaccines </li></ul><ul><li>Highlights the operation of major vaccine manufacturers in China. </li></ul>Please visit our website to order this report and find more information about other titles at www.researchinchina.com Related Products China Human Vaccine Industry Report, 2010-2011 China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010 China Interventional Cardiovascular Device Industry Report, 2010 China Insulin Industry Report, 2010 China Medical Imaging Device Industry Report, 2010 China Medical Monitor Industry Report, 2010
  3. 3. <ul><li>Market Scale and YoY Growth Rate of China Animal Vaccine Industry, 2006-2010 (Unit: RMB bn) </li></ul><ul><li>Source: ResearchInChina </li></ul><ul><li>   </li></ul>Abstract China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the increase of the state investment in animal epidemic funds, the expansion of compulsory immunization against animal epidemics and immunization scope as well as the strengthening of China livestock breeding industry standardization, China animal vaccine industry is expected to continue to maintain a relatively high growth momentum in future. Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few enterprises. CAHIC, Yebio QD, Guangdong Dahuanong Animal Health Products, Tecon and Chengdu Tech-Bank are representatives of China animal vaccine industry, accounting for a market share of 37.4%. Sales of these companies mainly come from the government procurement of compulsory vaccines, wherein, the revenue from government compulsory vaccines accounted for 88% of the total animal vaccine revenue of CAHIC in 2010.
  4. 4. <ul><li>In recent year, the scope of China animal compulsory vaccination is </li></ul><ul><li>being gradually expanded. Constrained by economic conditions, the </li></ul><ul><li>compulsory immunization against animal epidemics currently only </li></ul><ul><li>contains five kinds of Epidemics of Class I, while there are about 17 </li></ul><ul><li>kinds of Epidemic of Class I in China and other epidemics lead to </li></ul><ul><li>greater risk as well. With the increasing recognition of animal </li></ul><ul><li>epidemic prevention and control from breeding enterprises and </li></ul><ul><li>individuals, the future demand for conventional self-pay vaccine will </li></ul><ul><li>be further enhanced. As China livestock breeding relies mainly on </li></ul><ul><li>raising pig and poultry, Newcastle disease vaccine and porcine </li></ul><ul><li>circovirus vaccine will be two conventional vaccines with pretty good </li></ul><ul><li>market prospects. </li></ul><ul><li> </li></ul><ul><li> </li></ul>According to China’s compulsory immunization plan against animal epidemics in recent three years, China not only expands the application scope of the existing animal immunization products, but also attaches great importance to the upgrading of animal vaccine products at the same time. The applications of high-performance passage cell-derived vaccine, synthesis peptide vaccine, etc. are gradually being expanded, e.g., Classical Swine Fever Vaccine, Live (Cell Line Origin) expanded its application coverage from eight provinces in 2010 to sixteen provinces in 2011. However, due to the high requirements on technology and equipment from passage cell-derived vaccine, synthesis peptide vaccine, etc., there are limited manufacturers available right now. Although CAHIC, Tecon, etc all start their layout in the field of Classical Swine Fever Vaccine, Live (Cell Line Origin), Guangdong Winsun Bio-pharmaceutical is still the major supplier in present market. Tecon, Shanghai Shenlian, CAHIC, etc involve in production and sales of synthesis peptide vaccine, but CAHIC produces synthesis peptide vaccine by purchasing antigen from Shanghai Shenlian.  
  5. 5. <ul><li>4.1.4 Porcine Circovirus Vaccine </li></ul><ul><li>4.2 Poultry Vaccines </li></ul><ul><li>4.2.1 Newcastle Disease Vaccine </li></ul><ul><li>4.3 Cattle & Sheep Vaccines </li></ul><ul><li>4.4 Pet Vaccines </li></ul><ul><li>5. Key Enterprises </li></ul><ul><li>5.1 CAHIC </li></ul><ul><li>5.1.1 Profile </li></ul><ul><li>5.1.2 Operation </li></ul><ul><li>5.1.3 Animal Vaccine Business </li></ul><ul><li>5.1.4 Development Prospect & Advantages of Animal Vaccine Business </li></ul><ul><li>5.2 Jinyu Group </li></ul><ul><li>5.2.1 Profile </li></ul><ul><li>5.2.2 Operation </li></ul><ul><li>5.2.3 Animal Vaccine Business </li></ul><ul><li>5.2.4 Development Prospect & Advantages of Animal Vaccine Business </li></ul><ul><li>5.3 Tecon </li></ul><ul><li>5.3.1 Profile </li></ul><ul><li>5.3.2 Operation </li></ul><ul><li>5.3.3 Animal Vaccine Business </li></ul><ul><li>5.3.4 Development Prospect of Animal Vaccine Business </li></ul><ul><li>5.4 Ningbo Tech-Bank </li></ul><ul><li>5.4.1 Profile </li></ul><ul><li>5.4.2 Operation </li></ul><ul><li>5.4.3 Chengdu Tech-Bank (formerly Chengdu Jinghua) </li></ul>1. Overview of Animal Vaccine 1.1 Definition & Classification of Animal Vaccines 1.2 Definition & Classification of Animal Biological Products 1.3 Industry Chain 2. Operating Environment for Animal Vaccine Industry 2.1 Macro Environment 2.2 Policy Environment 2.3 Social Environment 2.4 International Environment 2.4.1 Market Scale 2.5 Overview of Vaccine Market 3. Development of Animal Vaccine Industry in China 3.1 Overview 3.2 Market Scale 3.3 Supply & Demand 3.4 Market Competition 3.5 Import and Export 3.5.1 Export 3.5.2 Import 3.6 Development Prospect 4. Animal Vaccine Market Segments in China 4.1 Swine Vaccines 4.1.1 Classical Swine Fever Vaccine 4.1.2 Pig Foot and Mouth Disease Vaccine 4.1.3 PRRS Vaccine Table of contents 5.5 Shenghua Biok 5.5.1 Profile 5.5.2 Operation 5.5.3 Yebio QD 5.6 Huasun Group 5.6.1 Profile 5.6.2 Operation 5.6.3 Sichuan Huasun 5.7 Harbin Pharmaceutical Group 5.7.1 Profile 5.7.2 Status Quo & Prospect of Animal Vaccine Business 5.8 Tianjin Ringpu Bio-technology 5.8.1 Profile 5.8.2 Operation 5.8.3 Status Quo & Prospect of Animal Vaccine Business 5.9 Guangdong Dahuanong Animal Health Products 5.9.1 Profile 5.9.2 Operation 5.9.3 Status Quo & Prospect of Animal Vaccine Business 5.10 Foreign Enterprises in China 5.10.1 Merial 5.10.2 Boehringer-Ingelheim 5.10.3 Bayer 5.10.4 Novartis 5.10.5 Pfizer
  6. 6. <ul><li>Animal Vaccine Types and Characteristics </li></ul><ul><li>Animal Vaccine Industry Chain </li></ul><ul><li>Amount of Livestock on Hand in China, 2005-2010 </li></ul><ul><li>Classification of Animal Disease </li></ul><ul><li>China’s GDP Growth Rate, 2007-2011Q2 </li></ul><ul><li>Major Policies Related to Animal Vaccine Industry, As of 2010 </li></ul><ul><li>China’s Meat, Poultry & Egg and Milk Output, 2007-2010 </li></ul><ul><li>Global Animal Vaccine Market Scale, 2004 & 2008-2010 </li></ul><ul><li>Vaccine Sales of Global Top 5 Vaccine Manufacturers, 2007-2010 </li></ul><ul><li>Main Mergers & Acquisitions in the Vaccine Industry Worldwide, 2005-Apr.2011 </li></ul><ul><li>Market Size of Human Vaccine and Animal Vaccine in China, 2007-2010 </li></ul><ul><li>EPI Vaccine Varieties in China, 2010 </li></ul><ul><li>Gross Margin of Major Vaccine Manufacturers in China, 2007-2010 </li></ul><ul><li>Mandatory Animal Disease Immunization Programs of China, 2009-2011 </li></ul><ul><li>China’s Animal Vaccine Market Share by Category, 2009-2010 </li></ul><ul><li>China’s Animal Vaccine Industry Market Scale & Growth, 2006-2010 </li></ul><ul><li>Major Manufacturers of Animal Vaccines in China </li></ul><ul><li>Production of China’s Key Animal Vaccine Manufacturers </li></ul><ul><li>China’s Animal Vaccine Consumption Structure by Animal Species, 2009-2010 </li></ul><ul><li>China’s Animal Vaccination Program, 2011 </li></ul><ul><li>Market Shares of China’s Main Animal Vaccine Manufacturers by Sales, 2010 </li></ul><ul><li>Manufacturers of Government Procurement Vaccines, 2008-2010 </li></ul><ul><li>Compulsory Vaccination Products of Listed Animal Vaccine Companies, 2010 </li></ul><ul><li>China’s Animal Vaccine Export Volume, Value and Average Unit Price, 2007-2010 </li></ul><ul><li>China’s Animal Vaccine Oversea Market Distribution, 2010 </li></ul>Selected Charts
  7. 7. <ul><li>China’s Animal Vaccine Import Volume, Value and Average Unit Price, 2007-2010 </li></ul><ul><li>Origins of China’s Imported Animal Vaccines, 2010 </li></ul><ul><li>China’s Animal Vaccine Industry Development Driving Forces </li></ul><ul><li>M & A of Animal Vaccine Enterprises in China, by Aug 2011 </li></ul><ul><li>China’s Pig Inventory and Slaughter Quantity, 2000-2010 </li></ul><ul><li>China’s Pig Vaccine Market Scale, 2008-2010 </li></ul><ul><li>China’s Pet Vaccine Suppliers </li></ul><ul><li>Performance Comparison of China’s Various Hog Cholera Vaccines </li></ul><ul><li>Designated FMD Vaccine Manufacturers and Their Market Shares, 2010 </li></ul><ul><li>PRRS Vaccine Prices </li></ul><ul><li>China’s Poultry Vaccine Market Scale, 2008-2010 </li></ul><ul><li>Major Poultry Vaccine Varieties and Manufacturers in China </li></ul><ul><li>Market Capacity of Newcastle Disease Vaccine and Market Share of Tianjin Ringpu Bio-technology </li></ul><ul><li>Cattle & Sheep Vaccine Market Scale, 2008-2010 </li></ul><ul><li>China’s Pet Vaccine Market Scale, 2008-2010 </li></ul><ul><li>Operating Revenue and Net Income of CAHIC, 2007-2011Q1 </li></ul><ul><li>Operating Revenue & Structure by Business of CAHIC, 2007-2010 </li></ul><ul><li>Operating Revenue of CAHIC by Region, 2008-2010 </li></ul><ul><li>Animal Vaccine Capacity Distribution of CAHIC </li></ul><ul><li>Animal Vaccine Sales Volume by Category of CAHIC, 2007-2010 </li></ul><ul><li>Animal Vaccine Operating Income and Gross Margin of CAHIC, 2007-2010 </li></ul><ul><li>Operating Revenue and Net Income of Jinyu Group, 2007-2011Q1 </li></ul><ul><li>Operating Revenue & Structure by Business of Jinyu Group, 2007-2010 </li></ul><ul><li>Operating Income and Operating Margin of Jinyu Group, 2008-2010 </li></ul><ul><li>Operating Revenue by Region of Jinyu Group, 2008-2010 </li></ul>Selected Charts
  8. 8. <ul><li>Animal Vaccine Capacity Distribution of Jinyu Group </li></ul><ul><li>Animal Vaccine Revenue and Gross Margin of Jinyu Group, 2007-2010 </li></ul><ul><li>R&D Advantages of Jinyu Group </li></ul><ul><li>Operating Revenue and Net Income of Tecon, 2007-2011Q1 </li></ul><ul><li>Operating Revenue and Structure by Business of Tecon, 2007-2010 </li></ul><ul><li>Operating Income and Operating Margin of Tecon, 2008-2010 </li></ul><ul><li>Ratio of R&D Input to Operating Revenue of Tecon, 2007-2010 </li></ul><ul><li>Operating Revenue by Region of Tecon, 2008-2010 </li></ul><ul><li>Animal Vaccine Revenue and Gross Margin of Tecon, 2007-2010 </li></ul><ul><li>Progress of Animal Vaccine R&D of Tecon, As of 2010 </li></ul><ul><li>Operating Revenue and Net Income of Ningbo Tech-Bank, 2008-2011Q1 </li></ul><ul><li>Operating Revenue and Structure by Business of Ningbo Tech-Bank, 2008-2010 </li></ul><ul><li>Gross Margin by Product of Ningbo Tech-Bank, 2008-2010 </li></ul><ul><li>Operating Revenue and Operating Income of Chengdu Tech-Bank, 2008-2010 </li></ul><ul><li>Operating Revenue and Net Income of Shenghua Biok, 2007-2011Q1 </li></ul><ul><li>Operating Revenue and Structure by Business of Shenghua Biok, 2007-2010 </li></ul><ul><li>Operating Margin of Shenghua Biok, 2007-2010 </li></ul><ul><li>Operating Revenue Structure of Shenghua Biok by Region, 2008-2010 </li></ul><ul><li>Operating Revenue and Net Income of Yebio QD, 2008-2010 </li></ul><ul><li>Operating Revenue and Net Income of Huasun Group, 2007-2011Q1 </li></ul><ul><li>Operating Revenue and Structure by Business of Huasun Group, 2008-2010 </li></ul><ul><li>Gross Margin by Business of Huasun Group, 2007-2010 </li></ul><ul><li>Operating Revenue and Net Income of Sichuan Huasun, 2008-2010 </li></ul><ul><li>Operation of Harbin Pharmaceutical Group, 2008-2009 </li></ul><ul><li>Operating Revenue and Net Income of Tianjin Ringpu Bio-technology, 2008-2011H1 </li></ul><ul><li>Sales of Tianjin Ringpu Bio-technology by Product, 2008-2010 </li></ul>Selected Charts
  9. 9. <ul><li>Gross Margin of Tianjin Ringpu Bio-technology by Product, 2007-2010 </li></ul><ul><li>Sales Revenue from Governmental Tendering and Its ratio of Tianjin Ringpu Bio-technology, 2008-2010 </li></ul><ul><li>R & D Input and Its Ratio to Operating Revenue of Tianjin Ringpu Bio-technology, 2008-2010 </li></ul><ul><li>Animal Vaccine Revenue of Tianjin Ringpu Bio-technology by Product, 2007-2010H1 </li></ul><ul><li>Operating Revenue and Net Income of Guangdong Dahuanong Animal Health Products, 2008-2011Q1 </li></ul><ul><li>Sales of Guangdong Dahuanong Animal Health Products by Product, 2008-2010 </li></ul><ul><li>Gross Margin of Guangdong Dahuanong Animal Health Products by Product, 2007-2010 </li></ul><ul><li>R & D Input and Its Ratio to Operating Revenue of Guangdong Dahuanong Animal Health Products, 2008-2010 </li></ul><ul><li>Main Animal Vaccine Products of Guangdong Dahuanong Animal Health Products </li></ul><ul><li>Vaccine Projects under R&D and Their Progress of Dahuanong Animal Health Products, As of 2010 </li></ul><ul><li>Animal Vaccine Products of Boehringer-Ingelheim in China Market, As of 2010 </li></ul>Selected Charts
  10. 10. <ul><li>You can place your order in the following alternative ways: </li></ul><ul><li>Order online at www.researchinchina.com </li></ul><ul><li>Fax order sheet to us at fax number:+86 10 82601570 </li></ul><ul><li>3. Email your order to: [email_address] </li></ul><ul><li>4. Phone us at +86 10 82600828/ 82600893 </li></ul>Choose type of format Hard copy …………………………2100 USD PDF (Single user license) ………......2000 USD PDF (Enterprisewide license)….. ......3100 USD ※ Reports will be dispatched immediately once full payment has been received. Payment may be made by wire transfer or credit card via Paypal. Room 1008, A2, Tower A, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080 Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● [email_address] How to Buy Party A: Name: Address: Contact Person: Tel E-mail: Fax Party B: Name: Beijing Waterwood Technologies Co., Ltd (ResearchInChina) Address: Room 1008, A2, Tower A, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080 Contact Person: Liao Yan Phone: 86-10-82600828 E-mail: [email_address] Fax: 86-10-82601570 Bank details: Beneficial Name: Beijing Waterwood Technologies Co., Ltd Bank Name: Bank of Communications, Beijing Branch Bank Address: NO.1 jinxiyuan shijicheng,Landianchang,Haidian District,Beijing Bank Account No #: 110060668012015061217 Routing No # : 332906 Bank SWIFT Code: COMMCNSHBJG Title Format Cost Total
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×